Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

The cortisol awakening response and major depression: examining the evidence.

Dedovic K, Ngiam J.

Neuropsychiatr Dis Treat. 2015 May 14;11:1181-9. doi: 10.2147/NDT.S62289. eCollection 2015. Review.

2.

Concordance of mother-daughter diurnal cortisol production: Understanding the intergenerational transmission of risk for depression.

LeMoult J, Chen MC, Foland-Ross LC, Burley HW, Gotlib IH.

Biol Psychol. 2015 May;108:98-104. doi: 10.1016/j.biopsycho.2015.03.019. Epub 2015 Apr 7.

PMID:
25862380
3.

Hypothalamic-pituitary-adrenal axis and behavioral dysfunction following early binge-like prenatal alcohol exposure in mice.

Wieczorek L, Fish EW, O'Leary-Moore SK, Parnell SE, Sulik KK.

Alcohol. 2015 May;49(3):207-17. doi: 10.1016/j.alcohol.2015.01.005. Epub 2015 Jan 26.

PMID:
25709101
4.

Decreased hypothalamic functional connectivity with subgenual cortex in psychotic major depression.

Sudheimer K, Keller J, Gomez R, Tennakoon L, Reiss A, Garrett A, Kenna H, O'Hara R, Schatzberg AF.

Neuropsychopharmacology. 2015 Mar;40(4):849-60. doi: 10.1038/npp.2014.259. Epub 2014 Oct 8.

PMID:
25292261
5.

Age-associated epigenetic upregulation of the FKBP5 gene selectively impairs stress resiliency.

Sabbagh JJ, O'Leary JC 3rd, Blair LJ, Klengel T, Nordhues BA, Fontaine SN, Binder EB, Dickey CA.

PLoS One. 2014 Sep 5;9(9):e107241. doi: 10.1371/journal.pone.0107241. eCollection 2014.

6.

Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Crowley SK, Girdler SS.

Psychopharmacology (Berl). 2014 Sep;231(17):3619-34. doi: 10.1007/s00213-014-3572-8. Epub 2014 Apr 23. Review.

7.
8.

Prospective association of morning salivary cortisol with depressive symptoms in mid-life: a life-course study.

Geoffroy MC, Hertzman C, Li L, Power C.

PLoS One. 2013 Nov 12;8(11):e77603. doi: 10.1371/journal.pone.0077603. eCollection 2013.

9.

Metyrapone in treatment-resistant depression.

Sigalas PD, Garg H, Watson S, McAllister-Williams RH, Ferrier IN.

Ther Adv Psychopharmacol. 2012 Aug;2(4):139-49. doi: 10.1177/2045125312436597.

10.

Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy.

Holland JM, Schatzberg AF, O'Hara R, Marquett RM, Gallagher-Thompson D.

Psychiatry Res. 2013 Dec 15;210(2):444-50. doi: 10.1016/j.psychres.2013.07.033. Epub 2013 Aug 14.

11.

Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study).

McAllister-Williams RH, Smith E, Anderson IM, Barnes J, Gallagher P, Grunze HC, Haddad PM, House AO, Hughes T, Lloyd AJ, McColl EM, Pearce SH, Siddiqi N, Sinha B, Speed C, Steen IN, Wainright J, Watson S, Winter FH, Ferrier IN.

BMC Psychiatry. 2013 Aug 3;13:205. doi: 10.1186/1471-244X-13-205.

12.

Sensitivity of depression-like behavior to glucocorticoids and antidepressants is independent of forebrain glucocorticoid receptors.

Vincent MY, Hussain RJ, Zampi ME, Sheeran K, Solomon MB, Herman JP, Khan A, Jacobson L.

Brain Res. 2013 Aug 7;1525:1-15. doi: 10.1016/j.brainres.2013.05.031. Epub 2013 May 28.

13.

Epigenetic Modulation of Mood Disorders.

Archer T, Oscar-Berman M, Blum K, Gold M.

J Genet Syndr Gene Ther. 2013 Feb 11;4(120). pii: 1000120.

14.

Exogenous glucocorticoids decrease subgenual cingulate activity evoked by sadness.

Sudheimer KD, Abelson JL, Taylor SF, Martis B, Welsh RC, Warner C, Samet M, Manduzzi A, Liberzon I.

Neuropsychopharmacology. 2013 Apr;38(5):826-45. doi: 10.1038/npp.2012.249. Epub 2012 Dec 3.

15.

A single-day treatment with mifepristone is sufficient to normalize chronic glucocorticoid induced suppression of hippocampal cell proliferation.

Hu P, Oomen C, van Dam AM, Wester J, Zhou JN, Joëls M, Lucassen PJ.

PLoS One. 2012;7(9):e46224. doi: 10.1371/journal.pone.0046224. Epub 2012 Sep 25.

16.

Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis.

Morris MC, Compas BE, Garber J.

Clin Psychol Rev. 2012 Jun;32(4):301-15. doi: 10.1016/j.cpr.2012.02.002. Epub 2012 Feb 10. Review.

17.

Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood.

Valiengo LL, Soeiro-de-Souza MG, Marques AH, Moreno DH, Juruena MF, Andreazza AC, Gattaz WF, Machado-Vieira R.

J Affect Disord. 2012 Apr;138(1-2):149-52. doi: 10.1016/j.jad.2011.11.046. Epub 2012 Feb 2.

18.

On the role of corticotropin-releasing hormone receptors in anxiety and depression.

Reul JM, Holsboer F.

Dialogues Clin Neurosci. 2002 Mar;4(1):31-46.

19.

Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population.

Appel K, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, Stender J, Barnow S, John U, Teumer A, Biffar R, Nauck M, Völzke H, Freyberger HJ, Grabe HJ.

Neuropsychopharmacology. 2011 Sep;36(10):1982-91. doi: 10.1038/npp.2011.81. Epub 2011 Jun 8.

20.

A placebo-controlled study of sertraline's effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults.

Carpenter LL, Tyrka AR, Lee JK, Tracy AP, Wilkinson CW, Price LH.

Psychopharmacology (Berl). 2011 Nov;218(2):371-9. doi: 10.1007/s00213-011-2336-y. Epub 2011 May 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk